Cite
HARVARD Citation
Tang, M. et al. (2022). Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer. Lung cancer. pp. 40-48. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tang, M. et al. (2022). Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer. Lung cancer. pp. 40-48. [Online].